West Harlem’s Volastra Therapeutics Appoints Charles Hugh-Jones As New CEO

Volastra Therapeutics, a biotechnology company developing novel therapies to treat and prevent the formation of metastatic disease, has named Charles Hugh-Jones, MD, FRCP, as its Chief Executive Officer. Continue Reading →


Quality independent publishing doesn't come free. Perhaps it goes without saying — but publishing isn't cheap. At a time when resources and revenue across the country are declining, Harlem World Magazine remains committed to sustaining our mission: creating a more engaged and informed Harlem with every story we cover and every newsletter we send and our work at H.Y.P.E. As a independent magazine, we rely on readers like you to help keep our stories free and our events open to the public. Do you value our independence? Show us with your support. YES, I'LL CONTRIBUTE TODAY! Thank you.